Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “benzoic acid”

62 pharma patents match "benzoic acid" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 62
Index total 30,257
Page 1 / 3

Quick answer

This filtered view shows 62 pharmaceutical patents matching "benzoic acid" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

62 results for “benzoic acid” · 30,257 patents in full index Clear search

  1. US 12065432

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted

  2. US 11052075

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  3. US 10959988

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  4. US 10618877

    Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

    PTC THERAPEUTICS, INC. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted

  5. US 10597384

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted

  6. US 10300047

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted May 28, 2019 · Expires May 23, 2039

    granted

  7. US 10233161

    Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

    PTC THERAPEUTICS, INC. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  8. US 10076513

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  9. US 10071081

    Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

    PTC THERAPEUTICS, INC. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  10. US 10028939

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted

  11. US 9969709

    Guanidinobenzoic acid ester compound

    Takeda Pharmaceutical Company Limited · Granted May 15, 2018 · Expires May 10, 2038

    granted

  12. US 9873677

    Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

    PTC THERAPEUTICS, INC. · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted

  13. US 9861617

    Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

    PTC THERAPEUTICS, INC. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  14. US 9840499

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted

  15. US 9776968

    Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted

  16. US 9611230

    1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  17. US 9434717

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted

  18. US 9321725

    Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

    Vertex Pharmaceuticals Incorporated · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  19. US 9314455

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  20. US 9309206

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4] oxadiazol-3-yl]-benzoic acid

    PTC THERAPEUTICS, INC. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  21. US 9241934

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted

  22. US 9205088

    Compositions of 1,2,4-oxadiazol benzoic acid compounds and methods for their use

    PTC THERAPEUTICS, INC. · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  23. US 9192606

    Dosage units of 3-(6-(1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  24. US 9150552

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.